AgingResearch.NewsJoin free

Early phase 1Status unknownGeroscience intervention

The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.

Sponsor
Shanghai Cell Therapy Group Co.,Ltd (Industry)
Enrolment
10 planned
Conditions
Enhance Immune Function
Interventions
NMN
Ages
adults, older adults
Registry
NCT05984550

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to investigate the changes in adult peripheral blood immune cell subpopulations, subpopulations, and cell functional status before and after intervention with Nicotinamide Mononucleotide (Vital NAD ) as NAD+ supplement for a certain period of time。To Explore and validate the biological functions of Nicotinamide Mononucleotide (Vital NAD ) of rejuvenation of the Peripheral blood immune cells of Adults.

Primary outcomes

  • Changes in Nicotinamide mononucleotide (Vital NAD) in whole blood.
  • Changes in NAD+ and NADH concentrations in whole blood.
  • The change of Blood cell indicators TBNK cells of the healthy adults at the points before and after intervention.
  • The change of Blood biochemical indicators of the healthy adults at the points before and after intervention.

History

  1. Study completion

  2. Primary completion

  3. Last registry update

  4. Started

  5. Registered